Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06792539 · ClinicalTrials.gov registry record · NA
Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty
A NA study of Degenerative Joint Disease of Hip and Dysplasia; Hip, sponsored by JointMedica.
- Recruiting
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 10
- Study locations
NCT06792539 is a NA study of Degenerative Joint Disease of Hip and Dysplasia; Hip that is actively recruiting participants, run by JointMedica. The registered enrollment target is 238 participants. The trial reports 10 study locations across 10 states.
The verdict
NCT06792539, a NA study of Degenerative Joint Disease of Hip and Dysplasia; Hip, is actively recruiting participants, sponsored by JointMedica.
- RECRUITING
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.
Conditions Studied
Interventions
- DEVICE Polymotion Hip Resurfacing (PHR) System
Study Locations (10)
Florida
- Florida Medical Clinic Orlando Health - Tampa
Illinois
- Rush University Medical Center - Chicago
Maryland
- Sinai Hospital / LifeBridge Health - Baltimore
New York
- NYU Longone - New York
Ohio
- Joint Implant Surgeons - New Albany
Oregon
- Oregon Health & Science University - Portland
South Carolina
- Midlands Orthopaedics & Neurosurgery - Columbia
Virginia
- Hampton Road Orthopaedics - Newport News
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2025-01-22 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06792539
The ClinicalTrials.gov registry entry for NCT06792539 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is JointMedica, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Degenerative Joint Disease of Hip appearing as the primary indexed condition, and to 1 intervention - of which Polymotion Hip Resurfacing (PHR) System is the first listed.
NCT06792539 reports 10 study locations spanning 10 distinct geographic areas - top geographies include Florida, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT06792539 about?
NCT06792539 is a clinical study titled "Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty". The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis,...
What is the current status of trial NCT06792539?
This trial is currently recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2025-01-22. Estimated completion is 2028-01.
What conditions does trial NCT06792539 study?
This clinical trial studies the following conditions: Degenerative Joint Disease of Hip, Dysplasia; Hip, Osteoarthritis of the Hip.
What interventions are being tested in trial NCT06792539?
The interventions under investigation include: Polymotion Hip Resurfacing (PHR) System (DEVICE).
Who is sponsoring clinical trial NCT06792539?
This trial is sponsored by JointMedica, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06792539 being conducted?
This trial has 10 study locations across Florida, Illinois, Maryland, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Joint Disease of Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.